OtherCellular and Molecular
ZM241385, DPCPX and MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor
Qilan Li, Kai Ye, Clara C. Blad, Hans den Dulk, Jaap Brouwer, Ad P. IJzerman and Margot W. Beukers
Journal of Pharmacology and Experimental Therapeutics October 31, 2006, DOI: https://doi.org/10.1124/jpet.106.111203
Qilan Li
Kai Ye
Clara C. Blad
Hans den Dulk
Jaap Brouwer
Ad P. IJzerman
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherCellular and Molecular
ZM241385, DPCPX and MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor
Qilan Li, Kai Ye, Clara C. Blad, Hans den Dulk, Jaap Brouwer, Ad P. IJzerman and Margot W. Beukers
Journal of Pharmacology and Experimental Therapeutics October 31, 2006, DOI: https://doi.org/10.1124/jpet.106.111203
OtherCellular and Molecular
ZM241385, DPCPX and MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor
Qilan Li, Kai Ye, Clara C. Blad, Hans den Dulk, Jaap Brouwer, Ad P. IJzerman and Margot W. Beukers
Journal of Pharmacology and Experimental Therapeutics October 31, 2006, DOI: https://doi.org/10.1124/jpet.106.111203
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement